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Background: 
Pregabalin is an anticonvulsant and analgesic agent that interacts selectively with the voltage-sensitive-Ca2＋- 
channel alpha-2-delta subunit. The aim of this study was to evaluate whether the analgesic action of intrathecal 
(IT) pregabalin is associated with KATP channels in the rat formalin test. 
Methods: 
IT PE-10 catheters were implanted in male Sprague-Dawley rats (250−300 g) under inhalation anesthesia 
using enflurane. Nociceptive behavior was defined as the number of hind paw flinches during 60 min after 
formalin injection. Ten min before formalin injection, IT drug treatments were divided into 3 groups: normal 
saline (NS) 20 μl (CON group); pregabalin 0.3, 1, 3 and 10 μg in NS 10 μl (PGB group); glibenclamide 100 
μg in DMSO 5 μl with pregabalin 0.3, 1, 3 and 10 μg in NS 5 μl (GBC group). All the drugs were flushed 
with NS 10 μl. Immunohistochemistry for the KATP channel was done with a different set of rats divided into 
naïve, NS and PGB groups. 
Results: 
IT pregabalin dose-dependently decreased the flinching number only in phase 2 of formalin test. The log 
dose response curve of the GBC group shifted to the right with respect to that of the PGB group. 
Immunohistochemistry for the KATP channel expression on the spinal cord dorsal horn showed no difference 
among the groups 1 hr after the formalin test. 
Conclusions: 
The antinociceptive effect of pregabalin in the rat formalin test was associated with the activation of the 
KATP channel. However, pregabalin did not induce KATP channel expression in the spinal cord dorsal horn. 
(Korean J Pain 2011; 24: 131-136)
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INTRODUCTION
    Pregabalin is an anticonvulsant analgesic agent that 
binds to the alpha-2-delta subunit of voltage sensitive Ca2＋ 
channels in the presynaptic area [1-5]. As for the site of 
action, intrathecal pregabalin reduces presynaptic neuro-
transmitter release without altering postsynaptic receptors 
[3]. However, gabapentin and pregabalin reduced the K＋- 
evoked glutamate release without affecting basal gluta-
mate levels [6]. And the actions of pregabalin may involve 
both extracellular and intracellular drug target sites and 
modulation of a variety of neuronal conductances, by direct 
interactions and through intracellular signaling involving 
protein kinase A [7].
    Opioid receptor agonists open K channels in neurons 
through the activation of G-proteins. The analgesic effect 
of morphine can be prevented by the inhibition of KATP 
channels and GIRK channels [8]. These 2 types of K chan-
nel activations lead to cell membrane hyperpolarization and 
are involved in opioid induced antinociception [9]. In addi-
tion, morphine activates presynaptic opioid G-protein- 
coupled mu-opioid receptors or inhibits calcium currents, 
thereby reducing neurotransmitter release [10]. 
    Gabapentin or pregabalin reduce excitatory neuro-
transmitter release by binding to the alpha-2-delta sub-
unit of voltage sensitive Ca2＋ channel even though they 
are not Ca2＋ blockers [2]. Pregabalin reduces the ex-
citatory properties of cultured DRG neurons by modulating 
voltage-activated Ca2＋ and K＋ channels [7]. On the other 
hand, the anti-allodynic effect of gabapentin was produced 
by the activation of Ca2＋ activated and ATP-sensitive K＋ 
channels [11]. These results led us to postulate that an as-
sociation between KATP channels and the analgesic effect 
of pregabalin may exist. In addition, if KATP channels are 
associated with pregabalin action, the evaluation of KATP 
channel expression in the spinal cord after intrathecal in-
jection of pregabalin will yield important information on the 
mechanism of the analgesic effect of pregabalin. 
    The aim of this study was to evaluate whether the an-
algesic action of intrathecal pregabalin is associated with 
KATP channels in the rat formalin test. In addition, the ef-
fect of pregabalin on KATP channel expression in the spinal 
cord dorsal horn was also evaluated.
MATERIALS AND METHODS
    This study was approved by the Institutional Animal 
Care Committee. Adult male Sprague-Dawley rats weigh-
ing 250-300 g were housed in individual cages on a 12 
h night/day cycle at a constant temperature of 20-22oC. 
Food and water were available ad libitum. 
1. Catheter implantation
    For intrathecal (IT) drug administration, rats were 
chronically implanted with catheters as previously de-
scribed [12]. Briefly, under enflurane anesthesia, the rat 
were placed in a stereotaxic head holder. The occipital 
muscles were separated and retracted caudal to expose the 
cisternal membrane at the base of the skull. A poly-
ethylene tube (PE-10 catheter) was passed caudally from 
the cisterna magna to the level of the lumbar enlargement. 
After bleeder ligation, the tissues were sutured layer by 
layer. Rats with evidence of neuromuscular dysfunction 
were promptly sacrificed. After 5-7 days of the catheter-
ization, rats without neurological deficit and infection were 
considered for data analysis. 
2. Neurobehavioral test
1) Drugs: Forty five rats were divided into 3 groups accord-
ing to the IT administered drug. In the control (CON) group 
(N = 5), normal saline 10 μl was administered as a placebo 
and flushed with normal saline 10 μl. In the pregabalin 
(PGB) group (N = 20), pregabalin 0.3, 1, 3 or 10 μg dis-
solved in normal saline 10 μl were administered and flushed 
with normal saline 10 μl. In the glibenclamide (GBC) group 
(N = 20), IT injection of glibenclamide 100 μg dissolved in 
dimethyl sulfoxide (DMSO) 5 μl was followed by pregabalin 
0.3, 1, 3, or 10 μg dissolved in normal saline 5 μl and 
flushed with normal saline 10 μl. 
2) Formalin test: After 10 min of IT drug administration, 
5% formalin solution 50 μl was injected intradermally to 
the dorsal surface of the left hind paw. Nociceptive behav-
ior was determined by the number of flinches of the left 
hind paw during 60 min. Flinching per minute was aver-
aged over 5 min. The initial 10 min was classified as phase 
1 and the next 11-60 min as phase 2. Maximum possible 
effect (%MPE) was calculated as follows:
(No. of flinching in control gr. - No. of flinching in experimental gr.) 
× 100
 No. of flinching in control gr.
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Fig. 1. Time course changes of flinching after intrathecal administration of pregabalin (A) and glibenclamide (GliB) with 
pregabalin (preg) (B) in the formalin test. Data are presented as the number of flinching. Each line represents the mean 
± SEM of bar in 5 rats.
3. Immunohistochemistry
1) Perfusion fixation: Immunohistochemitry was done sep-
arately with a different set of 13 rats. In the naïve group 
(N = 4), rats were deeply anesthetized 1 hr after admin-
istration of intrathecal normal saline 20 μl without formalin 
test. In both the normal saline group (N = 4) and pre-
gabalin group (N = 5), the formalin test was done 10 min 
after IT administration of normal saline 20 μl or pregabalin 
10 μg dissolved in normal saline 10 μl and flushed with 
normal saline 10 μl. Rats were deeply anesthetized and 
fixed by vascular perfusion with paraformaldehyde 1 hr af-
ter drug injection. The spinal cord was dissected and 
placed in 4% paraformaldehyde for an additional 2 h. Then 
the spinal cord was transferred to a 30% sucrose solution 
and incubated for 1 day at 4oC for cytoprotection. A micro-
tome (Leica Microsystems, Wetzlar, Germany) was used to 
cut 40 μm floating sections stored in phosphate buffer. 
Sections were rinsed 3 times in PBS then blocked in 4% 
goat serum and 0.3% Triton X-100. Antigen was retrieved 
by the heat induced epitope retrieval method after 
rehydration. Inactivation of endogenous peroxidase was 
conducted with 0.3% H2O2 incubated for 5 min at room 
temperature. After 3 more PBS rinses, sections were in-
cubated for 1 hour at room temperature and over-night 
with the primary antibodies (1：100 Kir 6.1 (H-80)) diluted 
in blocking buffer at 4oC. Sections were rinsed again with 
PBS and incubated for 20 min at room temperature with 
secondary antibodies (anti-rabbit IgG, Envision kit, DAKO: 
Santa Cruz Biotechnology, Inc. Santa Cruz, USA). The sli-
ces were counterstained with hematoxylin and dried before 
they were mounted with media. 
2) Imaging: Images were taken using a SP1 confocal mi-
croscope and image capturing software (Leica Microsys-
tems, Wetzlar, Germany). Quantifications were done using 
the Metamorph Imaging System software (Universal Imaging 
Corporation). Average pixel intensities within a region that 
approximated the laminae I-II of the ipsilateral spinal cord 
dorsal horn were calculated and normalized to a region of 
a comparable area in the contralateral dorsal horn. 
Threshold intensities were determined for each image 
above with most of the background noise suppressed. A 
rectangular box of constant size was placed over the entire 
width of the dorsal horn and the area of pixels within the 
box with an intensity value above the threshold was de-
termined for both the injured and uninjured side. The re-
sults are expressed as the percentage change in staining 
ipsilateral to the injury compared to the uninjured side. 
The calculated values of percent change for each section 
were then averaged to yield a value for each animal, and 
a mean and standard error were determined per group. 
The experimenter was blinded to the treatment group dur-
ing image collection and quantification. 
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Fig. 3. Results of Immunohistochemistry of KATP channel on the spinal cord dorsal horn (magnification of 10×). The results
of immunohistochemistry on the spinal cord dorsal horn shows no difference among the naïve group (A, no formalin test), 
normal saline group (B, IT normal saline 10 min before formalin injection) and pregabalin group (C, IT pregabalin 10 μg 
administered 10 min before formalin injection) in pixel intensities of KATP channel.
Fig. 2. Log dose response curve of intrathecal pregabalin.
Log dose response curve of intrathecal pregabalin (ED50 =
0.39 μg) shifted to the right (ED50 = 2.34 μg) when gliben-
clamide was added. *P ＜ 0.01 vs glibenclamide group.
4. Statistical analysis 
    All of the data were presented as the mean ± SEM. 
The dose-response data were expressed as %MPE in each 
phase. The dose response data was analyzed using one- 
way ANOVA with Scheffe for post hoc. The ED50 values 
were analyzed using dose-response analysis and the dif-
ference in the ED50 between the glibenclamide group and 
pregabalin group was analyzed with the student’s t-test. 
One-way ANOVA was used for comparison of the KATP 
channel expression in the spinal cord among groups. If the 
P value was less than 0.05, the results were considered 
statistically significant.
RESULTS 
1. Neurobehavioral test
1) After IT injection of pregabalin and/or glibenclamide, all 
animals showed no change in motor function such as the 
placing/stepping reflex and righting reflex tests. 
2) A subcutaneous injection of formalin resulted in a highly 
reliable biphasic display of flinching of the injected paw 
(Fig. 1A). IT injection of pregabalin decreased the sum of 
flinches in a dose dependent manner in phase 2 (P ＜ 
0.05), but not in phase 1. Additionally, a fixed dose of gli-
benclamide reversed the analgesic effects of pregabalin 
(Fig. 1B). 
3) The %MPE curve and ED50 of pregabalin shifted to the 
right in a log dose response curve compared to that of the 
glibenclamide pretreated rats (P ＜ 0.01)(Fig. 2).
2. Immunohistochemistry 
    The results of the immunohistochemistry on the spinal 
cord dorsal horn showed no difference among the naïve 
group (no formalin test), normal saline group (IT normal 
saline 20 μl 10 min before formalin injection) and pre-
gabalin group (IT pregabalin 10 μg administered 10 min 
before formalin injection) in pixel intensities for KATP chan-
nels (Fig. 3, Table 1).
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Table 1. Comparison of Expression of KATP Channel in the Spinal 
Cord Dorsal Horn
Group N Area change (%)
Naïve 
NS  
PGB  
4
4
5
−0.2 ± 0.3
−0.3 ± 0.2
−0.3 ± 0.3
Values are expressed as % mean area change ± SEM. NS: normal
saline, PGB: pregabalin.
DISCUSSION
    In the present study, IT pregabalin in a dose-depend-
ent manner decreased the number of flinching in phase 2 
of the formalin test and the log dose response curve IT 
pregabalin was shifted to the right when glibenclamide was 
added. There was no change in KATP channel expression in 
the spinal cord dorsal horn after IT pregabailn treatment 
in the formalin induced pain model. 
    In this study, the antinociceptive effect of IT pre-
gabalin was inhibited by glibenclamide, which suggests KATP 
channel activation as the antinociceptive mechanism of IT 
pregabalin. This is in agreement with a previous study, 
which reported that the antiallodynic effect of gabapentin 
in a spinal nerve ligation model was associated with ATP- 
sensitive K channels [11]. The KATP channel is known to ex-
ert its antinociceptive effect by regulating the excitability 
of peripheral neurons and inhibiting neurotransmitters 
such as substance P in the spinal cord [13-15]. This may 
explain the preemptive analgesic effect of pregabalin in 
this study
    A recent review demonstrated that although perioper-
ative pregabalin administration did not reduce pain in-
tensity, opioid consumption was significantly decreased 
during the first 24 h after surgery [16]. Gabapentin and 
pregabalin modulate the pain pathway by targeting the 
presynaptic Ca2＋ channel alpha-2-delta subunit, inhibiting 
K＋-induced Ca2＋ influx and reducing the release of pre-
synaptic glutamate and aspartate [17]. It has also been re-
ported that the KATP channel opening effect of pregabalin 
is one of the mechanism for reducing neuronal excitability 
[18]. In Chung’s model, an IT KATP inhibitor such as gliben-
clamide and a Ca2＋ activated K＋ channel inhibitor such as 
charybdotoxin and apamin reduced the antiallodynic effect 
of gabapentin [11]. A subsequent study showed that this ef-
fect was associated with the NO-cyclic GMP-PKG-K＋ 
channel pathway [19]. Nitric oxide (NO) is synthesized dur-
ing the pain process and it activates guanylate cyclase, 
which increases cGMP and opens the K＋ channel [20]. 
Administration of a (Rp)-analogue of c-AMP prevents an 
increase in K＋ current induced by pregabalin, which means 
that the intracellular response of pregabalin is associated 
with protein kinase A [7]. Another potassium channel sus-
pected to be associated with pain modulation is the big 
potassium (BK) channel, which is a large conductance Ca2＋ 
and voltage activated K＋ channel. Non-inactivating BK 
channels with low activity can be activated by protein kin-
ase A [21]. BK channel also have an important role in pain 
modulation and found in the dorsal root ganglion [22]. 
Therefore, BK channels can be a possible target of pre-
gabalin but further research is needed to clarify the 
mechanism. 
    Opening of the KATP channels results in an efflux of 
K＋ and occurs by membrane hyperpolarization and reduc-
tion in excitability. Therefore, the up-regulation of KATP 
channels have a protective effect when ischemia or re-
perfusion cause tissue injury by Ca2＋ overload and can be 
a promising target for pain control. However, our results 
showed that there is no change in channel expression for 
KATP in the spinal cord under the rat formalin test. This 
result is different from Yin’s report that Kir 6.2 mRNA ex-
pression was significantly increased after sciatic nerve in-
jury [23]. This may have resulted from the difference be-
tween the inflammatory pain model and the neuropathic 
pain model in terms of KATP channel involvement in the pain 
modulation process. 
    Our study has the following limitations. Animals for 
the immunohisochemistry analyses were sacrificed 1 hr af-
ter the formalin test and there was no difference in gene 
expression in our study. As with other studies the change 
in gene expression can be delayed up to 24 hours, and the 
result such that the expression of the KATP channels did 
not change at 1 hour after the formalin test. 
    The antinociceptive effect of pregabalin in the rat for-
malin test was indirectly associated with the activation of 
the KATP channels. However, pregabalin did not induce KATP 
channel expression in the spinal cord dorsal horn 1 hr after 
the formalin test. 
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